About Digital Pathology
Digital pathology is an image-based data environment, which is empowered by computer technology that takes into consideration the administration of data produced from a digital slide. It is empowered, to some degree, by virtual microscopy, which is the act of changing glass slides into digital slides that can be seen, managed, and analyzed on a computer monitor. With the appearance of whole slide imaging (WSI), the field of digital pathology has expanded vastly and at present viewed as the most promising among the field of diagnostic medicine to accomplish better, faster, and less expensive diagnosis, prognosis, and prediction of cancer and other important diseases.
Technavio’s analysts forecast the global digital pathology market to grow at a CAGR of 11.62% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global digital pathology market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of products associated with digital pathology.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Digital Pathology Market 2017-2021
Technavio recognizes the following companies as the key players in the global digital pathology market: 3DHISTECH, Danaher, F. Hoffmann-La Roche, Philips Healthcare, and OLYMPUS.
Other Prominent Vendors in the market are: Apollo Enterprise Imaging, Corista, Definiens, Glencoe Software, Hamamatsu Photonics, Indica Labs, Inspirata, Nikon Corporation, Omnyx, Objective Pathology Services, PerkinElmer, Pixcelldata, Sectra Medical Systems, Visiopharm, and XIFIN.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing application of digital pathology. Researchers are continuously working together to find new compounds or unusual tissue findings. In the case of epidemics, doctors and scientists need to reach as many peers as possible to figure out the diagnosis and the associated treatment. Digital pathology, in such circumstances, can provide time as well as cost-sensitive solutions.”
According to the report, one driver in the market is rising incidence of cancer. The incidences of cancer have been rising globally allowing for the increased use of digital pathology applications. According to an Organization for Economic Co-operation and Development (OECD) report, an expected 5.8 million new cancer cases were analyzed in OECD nations in 2012, of which 54% (around 3.1 million) occurred in men and 46% (around 2.7 million) in women. The most common were breast cancer (12.9% of all new cases) and prostate cancer (12.8%), followed by lung malignancy (12.3%) and colorectal cancer (11.9%). These four malignancies comprised half of the evaluated burden of cancer in OECD nations.
Further, the report states that one challenge in the market is high initial capital investment and excessive cost of digital pathology procedures. Innovation and technology are the focus areas in the field of pathology that facilitate efficient diagnosis and treatment. Digital pathology is one such technology through which many procedures in the field of pathology have become much easier and convenient to carry out. However, these procedures are costly. Scanning facilities can get more expensive depending on the required diagnosis and the nature of the procedure. This can affect the demand for procedures conducted with digital pathology products.
3DHISTECH, Danaher, F. Hoffmann-La Roche, Philips Healthcare, OLYMPUS, Apollo Enterprise Imaging, Corista, Definiens, Glencoe Software, Hamamatsu Photonics, Indica Labs, Inspirata, Nikon Corporation, Omnyx, Objective Pathology Services, PerkinElmer, Pixcelldata, Sectra Medical Systems, Visiopharm, and XIFIN.